Skip to content
Disclosery

SYNTAX ADVISORS, LLC: CVS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of SYNTAX ADVISORS, LLC on CVS, newest first. How the timeline and the estimate are built.

SYNTAX ADVISORS, LLC held 9,969 CVS shares at 2023-09-30 per its 13F-HR filed 2023-11-13.

the latest 13F is the newest step

  1. period ended2023-09-30
    13F 9,969 shares
    Change vs previous 13F +890 shares

    0.61% of the 13F portfolio, value $696,036.

    13F-HR 0001999371-23-000132 filed by SYNTAX ADVISORS, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2023-06-30
    13F 9,079 shares
    Change vs previous 13F +273 shares

    0.51% of the 13F portfolio, value $627,631.

    13F-HR 0001398344-23-014768 filed by SYNTAX ADVISORS, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2023-03-31
    13F 8,806 shares
    Change vs previous 13F +2,066 shares

    0.5% of the 13F portfolio, value $654,374.

    13F-HR 0001398344-23-009718 filed by SYNTAX ADVISORS, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2022-12-31
    13F 6,740 shares
    Change vs previous 13F -387 shares

    0.52% of the 13F portfolio, value $628,101.

    13F-HR 0001398344-23-003403 filed by SYNTAX ADVISORS, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2022-09-30
    13F 7,127 shares
    Change vs previous 13F not available

    0.58% of the 13F portfolio, value $680,000.

    13F-HR 0001398344-22-022030 filed by SYNTAX ADVISORS, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).